Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment
NCT02676375Phase 4Completed
- Sponsor
- Brentwood Biomedical Research Institute
- Start
- Jan 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupropion, nicotine in nicotine dependence, sponsored by Brentwood Biomedical Research Institute. Started Jan 2014; status: completed.
02
Drugs
bupropionnicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02676375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02676375.